P/Q‐type and T‐type voltage‐gated calcium channels are involved in the contraction of mammary and brain blood vessels from hypertensive patients
- 29 June 2016
- journal article
- Published by Wiley in Acta Physiologica
- Vol. 219 (3) , 642-653
Abstract
Aim: Calcium channel blockers are widely used in cardiovascular diseases. Besides L‐type channels, T‐ and P/Q‐type calcium channels are involved in the contraction of human renal blood vessels. It was hypothesized that T‐ and P/Q‐type channels are involved in the contraction of human brain and mammary blood vessels.Methods: Internal mammary arteries from bypass surgery patients and cerebral arterioles from patients with brain tumours with and without hypertension were tested in a myograph and perfusion set‐up.PCRand immunohistochemistry were performed on isolated blood vessels.Results: The P/Q‐type antagonist ω‐agatoxinIVA(10−8 mol L−1) and the T‐type calcium blocker mibefradil (10−7 mol L−1) inhibitedKCl depolarization‐induced contraction in mammary arteries from hypertensive patients with no effect on blood vessels from normotensive patients. ω‐AgatoxinIVAdecreased contraction in cerebral arterioles from hypertensive patients. L‐type blocker nifedipine abolished the contraction in mammary arteries.PCRanalysis showed expression of P/Q‐type (Cav2.1), T‐type (Cav3.1 and Cav3.2) and L‐type (Cav1.2) calcium channels in mammary and cerebral arteries. Immunohistochemical labelling of mammary and cerebral arteries revealed the presence of Cav2.1 in endothelial and smooth muscle cells. Cav3.1 was also detected in mammary arteries.Conclusion: P/Q‐ and T‐type Cavare present in human internal mammary arteries and in cerebral penetrating arterioles. P/Q‐ and T‐type calcium channels are involved in the contraction of mammary arteries from hypertensive patients but not from normotensive patients. Furthermore, in cerebral arterioles P/Q‐type channels importance was restricted to hypertensive patients might lead to that T‐ and P/Q‐type channels could be a new target in hypertensive patients.Keywords
Funding Information
- Sundhed og Sygdom, Det Frie Forskningsråd (11-107552)
- Hjerteforeningen (11-04-R84-A3492-22663)
This publication has 51 references indexed in Scilit:
- Myogenic tone is impaired at low arterial pressure in mice deficient in the low‐voltage‐activatedCaV3.1T‐typeCa2+channelActa Physiologica, 2013
- Functional and pharmacological consequences of the distribution of voltage‐gated calcium channels inthe renal blood vesselsActa Physiologica, 2013
- Regulation and function of Cav3.1 T-type calcium channels in IGF-I-stimulated pulmonary artery smooth muscle cellsAmerican Journal of Physiology-Cell Physiology, 2011
- α1G-dependent T-type Ca2+ current antagonizes cardiac hypertrophy through a NOS3-dependent mechanism in miceJournal of Clinical Investigation, 2009
- Effects of Benidipine, a Long-Acting T-Type Calcium Channel Blocker, on Home Blood Pressure and Renal Function in Patients with Essential HypertensionClinical Drug Investigation, 2009
- Regulation of T-type calcium channels: Signalling pathways and functional implicationsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- The Ca V 3.2 T-Type Ca 2+ Channel Is Required for Pressure Overload–Induced Cardiac Hypertrophy in MiceCirculation Research, 2009
- Bradycardia and Slowing of the Atrioventricular Conduction in Mice Lacking Ca V 3.1/α 1G T-Type Calcium ChannelsCirculation Research, 2006
- Low voltage-activated calcium channels in vascular smooth muscle: T-type channels and AVP-stimulated calcium spikingAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channelNature Genetics, 1997